Back
Day Range
$47.87
$49.81
52-Week Range
$38.24
$62.15
Volume
9,967
50D / 200D Avg
$55.56
/
$51.89
Prev Close
$47.29
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 475.7 | 0.4 |
| P/B | 26.2 | 2.9 |
| ROE % | 5.4 | 3.8 |
| Net Margin % | 4.4 | 3.9 |
| Rev Growth 5Y % | -0.4 | 10.0 |
| D/E | 1.7 | 0.2 |
Key Takeaways
Revenue declined -0.37% annually over 5 years
Earnings grew 77.13% over the past year
Generating 205.65M in free cash flow
P/E of 475.66 — premium valuation
Cash machine — converts 138.22% of earnings into free cash flow
Growth
Revenue Growth (5Y)
-0.37%
Revenue (1Y)0.53%
Earnings (1Y)77.13%
FCF Growth (3Y)-16.35%
Quality
Return on Equity
5.44%
ROIC6.56%
Net Margin4.38%
Op. Margin18.41%
Safety
Debt / Equity
1.65
Current Ratio0.90
Interest Coverage3.29
Valuation
P/E Ratio
475.66
P/B Ratio26.16
EV/EBITDA119.36
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.53% | Revenue Growth (3Y) | 0.04% |
| Earnings Growth (1Y) | 77.13% | Earnings Growth (3Y) | -14.85% |
| Revenue Growth (5Y) | -0.37% | Earnings Growth (5Y) | -17.35% |
| Profitability | |||
| Revenue (TTM) | 3.40B | Net Income (TTM) | 148.79M |
| ROE | 5.44% | ROA | 1.53% |
| Gross Margin | 46.26% | Operating Margin | 18.41% |
| Net Margin | 4.38% | Free Cash Flow (TTM) | 205.65M |
| ROIC | 6.56% | FCF Growth (3Y) | -16.35% |
| Safety | |||
| Debt / Equity | 1.65 | Current Ratio | 0.90 |
| Interest Coverage | 3.29 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 475.66 | P/B Ratio | 26.16 |
| P/S Ratio | 20.82 | PEG Ratio | 1.47 |
| EV/EBITDA | 119.36 | Dividend Yield | 0.00% |
| Market Cap | 70.77B | Enterprise Value | 74.68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.40B | 3.38B | 3.40B | 4.17B | 3.45B |
| Net Income | 148.79M | 84.00M | 205.20M | 678.10M | 318.90M |
| EPS (Diluted) | 0.43 | 0.24 | 0.60 | 2.67 | 1.25 |
| Gross Profit | 1.57B | 1.52B | 1.57B | 2.20B | 1.84B |
| Operating Income | 625.69M | 437.20M | 543.90M | 1.14B | 933.40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9.71B | 10.10B | 9.76B | 6.98B | 5.70B |
| Total Liabilities | 5.85B | 6.21B | 7.00B | 4.32B | 3.98B |
| Shareholders' Equity | 2.71B | 2.76B | 2.07B | 1.99B | 1.26B |
| Total Debt | 4.45B | 4.56B | 5.31B | 2.54B | 2.08B |
| Cash & Equivalents | 541.17M | 813.40M | 379.20M | 165.90M | 342.80M |
| Current Assets | 1.77B | 2.11B | 1.96B | 2.02B | 1.80B |
| Current Liabilities | 1.97B | 1.44B | 1.33B | 1.80B | 1.55B |